Lung Monitoring Devices

Lung Monitoring Devices Market Outlook

The global lung monitoring devices market is projected to reach approximately USD 6.5 billion by 2035, growing at a compound annual growth rate (CAGR) of around 8.5% during the forecast period from 2025 to 2035. The increasing prevalence of respiratory diseases, coupled with rising healthcare expenditure, is a significant factor contributing to the growth of this market. Moreover, the advancement of technology in lung monitoring devices is facilitating early diagnosis and effective management of various conditions. Another contributing aspect is the growing demand for homecare settings, which are becoming increasingly popular due to their convenience and cost-effectiveness. As a result, the market is expected to see a substantial influx of innovative products aimed at enhancing patient care and monitoring capabilities.

Growth Factor of the Market

The lung monitoring devices market is witnessing robust growth due to several pivotal factors. The surge in air pollution levels and rising incidences of chronic respiratory diseases are driving the demand for effective monitoring solutions. Furthermore, the progress in telemedicine and digital health technologies has emerged as a catalyst, enabling remote patient monitoring and effective disease management. The increasing awareness of preventive healthcare, particularly among the aging population, is prompting healthcare providers to adopt advanced lung monitoring devices. Additionally, government initiatives aimed at improving healthcare infrastructure and funding for research and development in respiratory care are further bolstering the market growth. The integration of artificial intelligence and machine learning in lung monitoring devices is also anticipated to enhance diagnostic accuracy and treatment personalization, contributing significantly to the market's expansion.

Key Highlights of the Market

• The market is expected to grow at a CAGR of 8.5% from 2025 to 2035.
• North America holds the largest market share, driven by advanced healthcare infrastructure.
• Wearable devices are gaining popularity due to their convenience and ease of use.
• Chronic Obstructive Pulmonary Disease (COPD) remains the prominent application area.
• Increasing investments in telehealth solutions are creating new opportunities for market players.

By Product Type

Spirometers

Spirometers are essential tools in lung monitoring, primarily used to measure airflow and lung volumes, thereby assisting in the diagnosis of various respiratory conditions. These devices play a critical role in assessing lung function and are indispensable in managing chronic diseases such as asthma and COPD. The continuous advancements in spirometer technology, including the development of portable and digital versions, have significantly improved user accessibility and data accuracy. Due to their precision, spirometers are extensively utilized in both clinical and homecare settings, as they provide valuable insights into lung health and aid in treatment adjustments. Moreover, the rising awareness among healthcare professionals regarding the importance of regular lung function testing further propels the adoption of spirometers across various healthcare facilities.

Peak Flow Meters

Peak flow meters are crucial for monitoring the peak expiratory flow rate (PEFR) in patients with asthma and other respiratory conditions. They are simple-to-use, cost-effective devices that facilitate daily monitoring of asthma control, enabling individuals to manage their condition proactively. By regularly measuring PEFR, patients can identify early signs of asthma exacerbation, allowing timely interventions. The growing prevalence of asthma globally, especially among children and young adults, has spurred the demand for peak flow meters, contributing to their significant market share. Additionally, the ongoing development of smart peak flow meters, which can sync data with mobile applications and healthcare providers, is enhancing patient engagement and adherence to treatment plans.

Pulse Oximeters

Pulse oximeters are non-invasive devices widely used for monitoring blood oxygen saturation levels and heart rates in patients. They have become an integral part of respiratory care, especially in emergency and critical care settings. The rise in respiratory illnesses and the ongoing concern regarding oxygen saturation due to conditions like COVID-19 have propelled the demand for pulse oximeters. Both healthcare professionals and patients now rely heavily on these devices for quick assessments of respiratory function. Technological advancements, such as the introduction of wearable pulse oximeters, have further expanded their applications in homecare settings, enabling continuous monitoring and improving patient outcomes. The ease of use and rapid results provided by pulse oximeters make them essential components in the lung monitoring device market.

Capnographs

Capnographs are sophisticated devices that measure the concentration of carbon dioxide (CO2) in exhaled air, providing critical information about respiratory function and ventilation status. They are particularly valuable in monitoring patients under sedation or those with respiratory distress, as they allow for real-time assessment of respiratory efficiency. The demand for capnographs is increasing in various healthcare settings, including hospitals and ambulatory surgical centers, due to their ability to enhance patient safety and improve clinical outcomes. The growing awareness of the importance of monitoring end-tidal CO2 levels in both emergency and non-emergency situations is further boosting the adoption of capnographs. As technology progresses, innovations such as portable and smart capnographs are expected to penetrate the homecare market, thereby expanding their reach and functionality.

Gas Analyzers

Gas analyzers are advanced instruments used to measure the concentration of various gases, including oxygen and carbon dioxide, in respiratory applications. They play a pivotal role in diagnosing and managing conditions like COPD, asthma, and pulmonary hypertension. The increasing need for precise respiratory gas measurements in healthcare settings has led to a rise in the adoption of gas analyzers. Their ability to provide detailed insights into respiratory gas exchange allows healthcare providers to make informed decisions regarding patient care. Moreover, advancements in technology, including the integration of gas analyzers with other monitoring devices and the development of portable variants, are enhancing their functionality and accessibility, contributing to growth in the lung monitoring devices market.

By Application

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD) is one of the leading applications for lung monitoring devices, accounting for a significant portion of the market. COPD encompasses several conditions, including emphysema and chronic bronchitis, which result in persistent respiratory symptoms and airflow limitation. The increasing prevalence of COPD, driven by factors such as smoking and air pollution, necessitates effective monitoring and management strategies. Lung monitoring devices, including spirometers and pulse oximeters, are integral in evaluating lung function and oxygen levels in patients with COPD. These devices facilitate regular assessments, enabling healthcare providers to adjust treatment plans promptly. The growing awareness regarding early diagnosis and management of COPD is further propelling the demand for lung monitoring devices in this application area.

Asthma

Asthma is another key application area for lung monitoring devices, with a rising number of individuals being diagnosed globally. The management of asthma requires regular monitoring of lung function to prevent exacerbations and improve overall quality of life. Devices such as peak flow meters and spirometers are essential tools in this regard, as they allow patients to track their symptoms and adhere to their treatment regimens effectively. As awareness about asthma management increases among patients and healthcare providers, the demand for lung monitoring devices specifically designed for asthma care is expected to grow substantially. The integration of digital technologies with these devices is also enhancing patient engagement, making it easier for individuals to manage their condition proactively.

Respiratory Distress Syndrome

Respiratory Distress Syndrome (RDS) is a significant concern, particularly among premature infants and those with underlying health issues. The use of lung monitoring devices is crucial in diagnosing and managing RDS, ensuring that timely interventions can be made to improve patient outcomes. Capnographs and gas analyzers play vital roles in this application by providing continuous monitoring of respiratory function and gas exchange. As the incidence of RDS rises, particularly in neonatal care, the demand for advanced lung monitoring devices tailored for this application is expected to increase. The growing focus on enhancing neonatal care and the use of advanced technologies in hospitals are further driving the adoption of monitoring devices for RDS.

Cystic Fibrosis

Cystic Fibrosis (CF) is a hereditary disorder that significantly affects lung function and requires ongoing monitoring and management. The use of lung monitoring devices is vital in assessing lung function and managing treatment plans for individuals with CF. Spirometers and pulse oximeters are commonly used to monitor respiratory status and guide therapy. The increasing prevalence of CF and the growing awareness of the importance of regular lung function assessments are boosting the demand for effective monitoring solutions. Advances in technology and the availability of portable monitoring devices are further enhancing the management of CF, allowing patients to monitor their health more effectively outside clinical settings.

Others

Other applications of lung monitoring devices include various respiratory conditions and diseases that require careful monitoring of lung function. This segment encompasses a range of disorders, including pneumonia, pulmonary hypertension, and lung infections. The demand for lung monitoring devices in these applications is driven by the need for accurate and timely assessment of respiratory function, particularly in critical care settings. Innovations in lung monitoring technology are enabling healthcare providers to offer tailored care solutions for patients with diverse respiratory needs. The increasing emphasis on personalized medicine and early diagnosis is expected to further fuel the growth of lung monitoring devices across these various applications.

By User

Hospitals

Hospitals are the largest end-users of lung monitoring devices, as they play a critical role in diagnosing and managing various respiratory conditions. The comprehensive range of devices used in hospitals allows healthcare providers to monitor patients continuously, ensuring timely interventions in critical situations. With the rising number of patients suffering from respiratory diseases, hospitals are increasingly adopting advanced lung monitoring technologies to improve patient care and outcomes. The integration of telemedicine and remote monitoring capabilities enables hospitals to enhance their service delivery and patient engagement. Furthermore, as hospitals continue to emphasize quality improvement initiatives, the demand for reliable and accurate lung monitoring devices is expected to grow significantly.

Clinics

Clinics represent another vital segment for the lung monitoring devices market, providing outpatient services for patients with respiratory conditions. The growing prevalence of respiratory diseases has led to an increased patient load in clinics, necessitating the need for effective monitoring solutions. Devices such as spirometers and peak flow meters are commonly used in clinics to facilitate routine assessments and patient education. The shift towards preventive healthcare and the focus on early diagnosis are encouraging clinics to invest in advanced lung monitoring devices, enabling them to offer better services and improve patient outcomes. Additionally, the availability of portable and user-friendly monitoring devices is making it easier for clinics to implement effective lung health management strategies.

Homecare Settings

Homecare settings are emerging as a significant user segment in the lung monitoring devices market, driven by the increasing preference for at-home patient care. Patients are increasingly seeking convenience in managing their respiratory diseases from home, spurring the demand for reliable and easy-to-use monitoring devices. Devices such as pulse oximeters and portable spirometers are particularly popular in homecare settings, as they enable individuals to monitor their lung function and oxygen levels autonomously. The growing awareness of chronic respiratory diseases, coupled with advancements in telehealth solutions, allows for continuous monitoring and timely interventions, enhancing patient safety and promoting self-management. The homecare segment's growth is expected to significantly impact the overall lung monitoring devices market, as more patients opt for personalized care in familiar environments.

Ambulatory Surgical Centers

Ambulatory Surgical Centers (ASCs) are increasingly adopting lung monitoring devices due to the rising number of outpatient surgical procedures that require respiratory assessments. The demand for efficient and accurate monitoring solutions in ASCs is driven by the need to ensure patient safety during and after surgery. Devices such as capnographs and gas analyzers are essential in monitoring patients' respiratory status in real-time, allowing for timely interventions. The trend towards minimally invasive surgeries and the focus on enhancing patient recovery times are also contributing to the increased adoption of lung monitoring devices in ASCs. As the healthcare landscape evolves towards outpatient care, the role of lung monitoring devices in ASCs is expected to grow significantly.

Others

Other users of lung monitoring devices include long-term care facilities, rehabilitation centers, and research institutions. Each of these sectors requires effective monitoring solutions to manage patients with respiratory conditions. Long-term care facilities, for instance, are increasingly adopting lung monitoring devices to improve care for elderly patients with chronic respiratory diseases. Similarly, rehabilitation centers utilize these devices to track progress in patients recovering from respiratory issues. Research institutions are also leveraging lung monitoring technologies to advance studies in respiratory health. The diverse applications of lung monitoring devices across various user segments highlight their significance in improving respiratory care and patient outcomes.

By Technology

Wearable Devices

Wearable lung monitoring devices are revolutionizing the way respiratory health is monitored, as they allow continuous tracking of lung function in a non-invasive manner. These devices, which can be worn on the body, track parameters such as oxygen saturation, respiratory rate, and physical activity levels. The growing popularity of wearable devices can be attributed to their convenience and the increasing demand for remote patient monitoring solutions, especially among individuals with chronic respiratory diseases. The integration of smart technologies and mobile applications enhances user engagement, enabling patients to take a proactive approach to their respiratory health. Additionally, advancements in sensor technology are improving the accuracy and reliability of wearable lung monitoring devices, further propelling their adoption in both clinical and homecare settings.

Non-Wearable Devices

Non-wearable lung monitoring devices encompass a range of equipment used primarily in clinical and hospital settings. These devices, including spirometers, peak flow meters, and gas analyzers, are essential for conducting detailed assessments of lung function and respiratory health. Non-wearable devices are characterized by their precision and reliability, making them indispensable tools for healthcare professionals. The growing focus on diagnostics and monitoring in healthcare is driving the demand for non-wearable lung monitoring devices, as they provide critical information for managing respiratory conditions. Furthermore, technological advancements in this segment, such as the development of compact and user-friendly devices, are expanding their applications and enhancing their utility in a wide array of healthcare settings.

By Region

In terms of regional analysis, North America holds the largest share of the lung monitoring devices market, accounting for over 40% of the total market revenue. This dominance is primarily attributed to advanced healthcare infrastructure, high disposable incomes, and a strong presence of key market players in the region. The increasing prevalence of chronic respiratory diseases, along with a heightened focus on preventive healthcare, is driving the demand for innovative lung monitoring solutions. The region is expected to grow at a CAGR of 8% during the forecast period, reflecting continued investments in healthcare technology and the emphasis on improving patient outcomes.

Europe is the second-largest market for lung monitoring devices, contributing approximately 30% to the global market share. The region is experiencing significant growth due to the rising incidences of respiratory diseases, coupled with increasing healthcare expenditures and government initiatives aimed at enhancing respiratory care. The integration of telemedicine and digital health solutions is also promoting the adoption of lung monitoring devices in Europe. The Asia Pacific region is anticipated to witness the highest growth rate during the forecast period, driven by rapid urbanization, increasing pollution levels, and rising awareness regarding respiratory health. This region is expected to grow at a CAGR of 10% as countries focus on enhancing their healthcare infrastructure and improving access to medical technologies.

Opportunities

The lung monitoring devices market presents numerous opportunities for growth, particularly through innovation and technological advancements. The increasing prevalence of respiratory diseases globally is creating a pressing need for effective monitoring solutions. Companies are encouraged to invest in research and development to create advanced, user-friendly devices that cater to the needs of patients and healthcare providers alike. The integration of artificial intelligence and machine learning into lung monitoring technologies is an emerging trend that could enhance diagnostic accuracy and improve treatment outcomes. Furthermore, the expansion of telehealth services and remote patient monitoring solutions represents a significant opportunity for market players to tap into new consumer bases and offer more comprehensive care models, particularly in the wake of global health crises such as the COVID-19 pandemic.

Another opportunity lies in the growing demand for homecare settings, where patients prefer to manage their respiratory conditions from the comfort of their homes. The ability to monitor lung function remotely not only provides convenience but also empowers patients to take charge of their health. As technology continues to evolve, manufacturers have the chance to develop portable and smart lung monitoring devices that seamlessly integrate with telehealth platforms. Additionally, collaborations between healthcare providers and technology companies can lead to the creation of tailored solutions that enhance patient engagement and adherence to treatment plans. These opportunities for innovation and strategic partnerships are expected to drive the lung monitoring devices market forward in the coming years.

Threats

Despite the promising growth prospects, the lung monitoring devices market faces several threats that could impede its progress. One of the primary challenges is the stringent regulatory landscape governing medical devices, which requires manufacturers to adhere to rigorous safety and quality standards. The lengthy approval process for new devices can delay market entry and increase development costs, posing a significant barrier for smaller companies seeking to innovate. Furthermore, the rapid evolution of technology means that companies must continuously invest in research and development to remain competitive, which can strain financial resources. Additionally, the emergence of alternative therapies, such as pharmacological interventions and lifestyle modifications, may reduce the reliance on monitoring devices, impacting overall market growth.

Another concern is the risk of data privacy and security breaches, particularly with the increasing adoption of connected and smart devices. Patients are becoming more aware of the potential risks associated with sharing their health data, which could lead to hesitancy in adopting new technologies. Moreover, the ongoing economic fluctuations and uncertainties in healthcare funding may affect investments in new technologies, thereby impacting the overall growth of the lung monitoring devices market. Companies must proactively address these threats through robust compliance strategies and data protection measures to maintain consumer trust and ensure sustainable growth.

Competitor Outlook

• Philips Healthcare
• Medtronic
• Honeywell
• GE Healthcare
• Smiths Medical
• Omron Healthcare
• Masimo Corporation
• Vitalograph
• Rudolph Technologies
• Fujifilm Holdings Corporation
• Welch Allyn
• Mindray Medical International
• Schiller AG
• CareFusion (Becton, Dickinson and Company)
• Nonin Medical

The competitive landscape of the lung monitoring devices market is characterized by a diverse range of players, from established multinational corporations to emerging startups. Key players such as Philips Healthcare and Medtronic have a strong foothold in the market, leveraging their extensive product portfolios and established brand recognition to capture significant market share. These companies continuously invest in research and development to introduce innovative products and enhance existing ones, ensuring they remain at the forefront of technological advancements in lung monitoring. Additionally, strategic partnerships and collaborations with healthcare providers and technology firms have become commonplace, allowing these companies to expand their market reach and improve service delivery.

Emerging players in the lung monitoring devices market are also making their presence felt, particularly by focusing on niche segments and developing cutting-edge technologies. Companies like Masimo Corporation and Omron Healthcare are gaining traction by introducing innovative monitoring solutions that cater to the growing demand for homecare and remote monitoring. These players often adopt agile operational models and prioritize customer engagement, enabling them to respond quickly to market needs and preferences. The influx of digital health startups is further intensifying competition, as they seek to capitalize on the growing trend of connected health devices and telehealth services.

Major companies such as Honeywell, GE Healthcare, and Smiths Medical are also notable participants in the lung monitoring devices market. They have established strong distribution networks and relationships with healthcare professionals, facilitating the widespread adoption of their products. These companies focus on enhancing user experience through intuitive designs and seamless integration with existing healthcare systems. Additionally, they prioritize regulatory compliance and quality assurance, ensuring that their products meet the highest standards of safety and efficacy. As the market evolves, these lead players are expected to adapt their strategies to stay competitive while exploring new growth avenues in line with emerging trends and consumer demands.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Honeywell
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Schiller AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Vitalograph
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Welch Allyn
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 GE Healthcare
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Nonin Medical
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Smiths Medical
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Omron Healthcare
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Masimo Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Philips Healthcare
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Rudolph Technologies
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Fujifilm Holdings Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Mindray Medical International
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 CareFusion (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Lung Monitoring Devices Market, By User
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Homecare Settings
    • 6.1.4 Ambulatory Surgical Centers
    • 6.1.5 Others
  • 6.2 Lung Monitoring Devices Market, By Technology
    • 6.2.1 Wearable Devices
    • 6.2.2 Non-Wearable Devices
  • 6.3 Lung Monitoring Devices Market, By Application
    • 6.3.1 Chronic Obstructive Pulmonary Disease
    • 6.3.2 Asthma
    • 6.3.3 Respiratory Distress Syndrome
    • 6.3.4 Cystic Fibrosis
    • 6.3.5 Others
  • 6.4 Lung Monitoring Devices Market, By Product Type
    • 6.4.1 Spirometers
    • 6.4.2 Peak Flow Meters
    • 6.4.3 Pulse Oximeters
    • 6.4.4 Capnographs
    • 6.4.5 Gas Analyzers

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Lung Monitoring Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Lung Monitoring Devices market is categorized based on

By Product Type

• Spirometers
• Peak Flow Meters
• Pulse Oximeters
• Capnographs
• Gas Analyzers

By Application

• Chronic Obstructive Pulmonary Disease
• Asthma
• Respiratory Distress Syndrome
• Cystic Fibrosis
• Others

By User

• Hospitals
• Clinics
• Homecare Settings
• Ambulatory Surgical Centers
• Others

By Technology

• Wearable Devices
• Non-Wearable Devices

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Philips Healthcare
• Medtronic
• Honeywell
• GE Healthcare
• Smiths Medical
• Omron Healthcare
• Masimo Corporation
• Vitalograph
• Rudolph Technologies
• Fujifilm Holdings Corporation
• Welch Allyn
• Mindray Medical International
• Schiller AG
• CareFusion (Becton, Dickinson and Company)
• Nonin Medical